<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Turk J Haematol</journal-id>
      <journal-id journal-id-type="iso-abbrev">Turk J Haematol</journal-id>
      <journal-id journal-id-type="publisher-id">TJH</journal-id>
      <journal-title-group>
        <journal-title>Turkish Journal of Hematology</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1300-7777</issn>
      <issn pub-type="epub">1308-5263</issn>
      <publisher>
        <publisher-name>Galenos Publishing</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25912830</article-id>
      <article-id pub-id-type="pmc">4805316</article-id>
      <article-id pub-id-type="doi">10.4274/tjh.2014.0475</article-id>
      <article-id pub-id-type="publisher-id">1579</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Images in Hematology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Diagnosis: Melanoderma after Hematopoietic Stem Cell Transplantation</article-title>
        <trans-title-group xml:lang="tr">
          <trans-title>Hematopoetik K&#xF6;k H&#xFC;cre Nakli Sonras&#x131; Geli&#x15F;en Melanoderma</trans-title>
        </trans-title-group>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>&#xDC;nal</surname>
            <given-names>&#x15E;ule</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
          <xref ref-type="corresp" rid="COR1">*</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tezcan</surname>
            <given-names>&#x130;lhan</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>G&#xFC;&#xE7;er</surname>
            <given-names>&#x15E;afak</given-names>
          </name>
          <xref ref-type="aff" rid="A3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Boyraz</surname>
            <given-names>Meryem Seda</given-names>
          </name>
          <xref ref-type="aff" rid="A4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>&#xC7;a&#x11F;da&#x15F;</surname>
            <given-names>Deniz</given-names>
          </name>
          <xref ref-type="aff" rid="A2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>U&#xE7;kan &#xC7;etinkaya</surname>
            <given-names>Duygu</given-names>
          </name>
          <xref ref-type="aff" rid="A1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="A1"><label>1</label>
Hacettepe University Faculty of Medicine, Division of Pediatric Hematology, Ankara, Turkey
</aff>
      <aff id="A2"><label>2</label>
Hacettepe University Faculty of Medicine, Division of Immunology, Ankara, Turkey
</aff>
      <aff id="A3"><label>3</label>
Hacettepe University Faculty of Medicine, Division of Pediatric Pathology, Ankara, Turkey
</aff>
      <aff id="A4"><label>4</label>
Hacettepe University Faculty of Medicine, Department of Pediatrics, Ankara, Turkey
</aff>
      <author-notes>
        <corresp id="COR1">* Address for Correspondence: Hacettepe University Faculty of Medicine, Division of Pediatric Hematology, Ankara, Turkey Phone: +90 312 305 11 70 E-mail: <email>suleunal@hacettepe.edu.tr</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>3</day>
        <month>12</month>
        <year>2015</year>
      </pub-date>
      <volume>32</volume>
      <issue>4</issue>
      <fpage>378</fpage>
      <lpage>379</lpage>
      <history>
        <date date-type="received">
          <day>12</day>
          <month>12</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>19</day>
          <month>1</month>
          <year>2015</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Turkish Journal of Hematology, Published by Galenos Publishing.&#xD;
</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <kwd-group>
        <kwd>Hematopoietic stem cell transplantation</kwd>
        <kwd>Melanoderma</kwd>
        <kwd>Skin findings</kwd>
        <kwd>SCID</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>QUIZ IN HEMATOLOGY</title>
      <p>An 8-month-oldboy diagnosed with T-B+NK- SCID underwent peripheral blood hematopoietic stem cell transplantation (HSCT) from MSD without conditioning. However, he developed pancytopenia and became transfusion dependent by post-transplant 2nd month. Bone marrow aspiration/biopsy revealed an aplastic marrow with 98% donor chimerism. With a diagnosis of T-cell engraftment of the donor but no engraftment of the other lineages, a 2nd HSCT with conditioning (BU/FLU/ATG) was performed at post-transplant +23rd month from the same donor. Due to hyperferritinemia pre-transplant desferoxamine was given. On post-transplant day +2, he developed hyperpigmented patches (<xref ref-type="fig" rid="f1">Figure 1</xref>). Platelet count was 22x109/L and aPTT and PT were normal. Platelet transfusion was given; however the lesions did not subside with the expected color change of ecchymoses. Skin biopsy from medial thigh was obtained (<xref ref-type="fig" rid="f2">Figure 2</xref>).</p>
      <p>Generalized hyperpigmentation, after conditioning, is a common finding after HSCT [<xref rid="ref1" ref-type="bibr">1</xref>]. However, in our patient the lesions were patchy. There are few reports of melanoderma [<xref rid="ref1" ref-type="bibr">1</xref>,<xref rid="ref2" ref-type="bibr">2</xref>] after HSCT and in one, melanoderma was reported as a finding of chronic GvHD [<xref rid="ref2" ref-type="bibr">2</xref>]. Based on the absence of clinical signs of GvHD and lack of typical histological evidence, the melanoderma in our patient was attributed to drugs used in conditioning. The transfusional iron loading may cause a generalized darkening of the skin; however in our patient the lesions were patchy and developed just after completion of the conditioning regimen and subsequent stem cell infusion. The patient did not develop acute or chronic GvHD signs throughout the follow-up. The lesions&#x2019; color faded after engraftment gradually, although did not disappear totally. Currently, the patient is alive at post-HSCT 6th month.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn id="FN3" fn-type="con">
        <p><bold>Informed Consent:</bold> Informed consent has been obtained from the parents of the patient, <bold>Concept:</bold> &#x15E;ule &#xDC;nal, &#x130;lhan Tezcan, &#x15E;afak G&#xFC;&#xE7;er, Meryem Seda Boyraz, Deniz &#xC7;a&#x11F;da&#x15F;, Duygu U&#xE7;kan &#xC7;etinkaya, <bold>Design:</bold> &#x15E;ule &#xDC;nal, &#x130;lhan Tezcan, &#x15E;afak G&#xFC;&#xE7;er, Meryem Seda Boyraz, Deniz &#xC7;a&#x11F;da&#x15F;, Duygu U&#xE7;kan &#xC7;etinkaya, <bold>Data Collection or Processing:</bold> &#x15E;ule &#xDC;nal, &#x130;lhan Tezcan, &#x15E;afak G&#xFC;&#xE7;er, Meryem Seda Boyraz, Deniz &#xC7;a&#x11F;da&#x15F;, Duygu U&#xE7;kan &#xC7;etinkaya, <bold>Analysis or Interpretation:</bold> &#x15E;ule &#xDC;nal, &#x130;lhan Tezcan, &#x15E;afak G&#xFC;&#xE7;er, Meryem Seda Boyraz, Deniz &#xC7;a&#x11F;da&#x15F;, Duygu U&#xE7;kan &#xC7;etinkaya, <bold>Literature Search:</bold> &#x15E;ule &#xDC;nal, &#x130;lhan Tezcan, &#x15E;afak G&#xFC;&#xE7;er, Meryem Seda Boyraz, Deniz &#xC7;a&#x11F;da&#x15F;, Duygu U&#xE7;kan &#xC7;etinkaya, <bold>Writing:</bold> &#x15E;ule &#xDC;nal, &#x130;lhan Tezcan, &#x15E;afak G&#xFC;&#xE7;er, Meryem Seda Boyraz, Deniz &#xC7;a&#x11F;da&#x15F;, Duygu U&#xE7;kan &#xC7;etinkaya.</p>
      </fn>
      <fn id="FN1" fn-type="conflict">
        <p><bold>Conflict of Interest:</bold> The authors of this paper have no conflicts of interest, including specific financial interests, relationships, and/or affiliations relevant to the subject matter or materials included.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="ref1">
        <label>1</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Aractingi</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Janin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Devergie</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bourges</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Socie</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Gluckman</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Histochemical and ultrastructural study of diffuse melanoderma after bone marrow transplantation</article-title>
          <source>Br J Dermatol</source>
          <year>1996</year>
          <volume>134</volume>
          <fpage>325</fpage>
          <lpage>331</lpage>
          <pub-id pub-id-type="pmid">8746350</pub-id>
        </element-citation>
      </ref>
      <ref id="ref2">
        <label>2</label>
        <element-citation publication-type="journal" publication-format="online">
          <person-group person-group-type="author">
            <name>
              <surname>Martin-Gorgojo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Mart&#xED;n</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Gavrilova</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Monteagudo</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Jord&#xE1;-Cuevas</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Chronic graft-versus-host disease presenting with coexisting diffuse melanoderma and hypopigmented patches: A peculiar presentation</article-title>
          <source>Eur J Dermatol</source>
          <year>2013</year>
          <volume>23</volume>
          <fpage>553</fpage>
          <lpage>555</lpage>
          <pub-id pub-id-type="pmid">23985139</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1" orientation="portrait" position="float">
      <label>Figure 1</label>
      <caption>
        <title>Patchy melanoderma lesions mimicking ecchymoses in the legs, trunk.</title>
      </caption>
      <graphic xlink:href="TJH-32-378-g1"/>
    </fig>
    <fig id="f2" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <title>A) Skin. A slight perivascular infiltration of mononuclear inflammatory cells and dermal melanophages (arrows) are seen (HEx200). B) An increment in melanin pigment in basal keratinocytes (arrow heads) and dermal melanophages (white arrows) are highlighted by Fontana-Masson stain (x200).</title>
      </caption>
      <graphic xlink:href="TJH-32-378-g2"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
